Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-092814
Filing Date
2024-08-07
Accepted
2024-08-07 16:15:24
Documents
47
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alec-20240630.htm   iXBRL 10-Q 1847782
2 EX-31.1 alec-ex31_1.htm EX-31.1 21050
3 EX-31.2 alec-ex31_2.htm EX-31.2 21047
4 EX-32.1 alec-ex32_1.htm EX-32.1 8352
5 EX-32.2 alec-ex32_2.htm EX-32.2 8331
  Complete submission text file 0000950170-24-092814.txt   5532389

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alec-20240630.xsd EX-101.SCH 683726
50 EXTRACTED XBRL INSTANCE DOCUMENT alec-20240630_htm.xml XML 722053
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38792 | Film No.: 241183965
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)